Acadia Pharmaceuticals (DR6.F) Q3 2024 Earnings

Aug 6Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.42
-0.19
0.04
0.27

Details

Expected EPS
0.16261424419999998
Actual EPS
0.183052
Surprise EPS
0.02
Surprise Percent
+12.57%

Description

⁨Acadia Pharmaceuticals⁩ (⁦DR6.F⁩) has reported earnings of ⁦0.183052⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts